<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1006788.ref093">
 <label>93</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Shi</surname>
   <given-names>L</given-names>
  </name>, 
  <name>
   <surname>Sings</surname>
   <given-names>HL</given-names>
  </name>, 
  <name>
   <surname>Bryan</surname>
   <given-names>JT</given-names>
  </name>, 
  <name>
   <surname>Wang</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Wang</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Mach</surname>
   <given-names>H</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>GARDASIL: prophylactic human papillomavirus vaccine development—from bench top to bed-side</article-title>. 
  <source>Clin Pharmacol Ther</source>. 
  <year>2007</year>;
  <volume>81</volume>: 
  <fpage>259</fpage>–
  <lpage>264</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/sj.clpt.6100055" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/sj.clpt.6100055</ext-link>
  </comment>
  <?supplied-pmid 17259949?>
  <pub-id pub-id-type="pmid">17259949</pub-id>
 </mixed-citation>
</ref>
